ER-803064

N/A

Report date: 2026/03/06 20:02:51
NME

Base Information

Drug NameER-803064
Drug Alias NameER-803064
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTGF-β activated kinase-1 inhibitors
TargetsTGF-β activated kinase-1
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEisai Research Institute of Boston Inc
China Registration ClassN/A

Develop Information

Active CompaniesEisai Research Institute of Boston Inc
Inactive CompaniesN/A
Active IndicationsInflammation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A